BCMU
CELG

BlueCrest Capital Management (UK)’s Celgene Corp CELG Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,216
Closed -$434K – 832
2014
Q1 		$434K Buy
+6,216
New +$492K 0.02% 384

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlueCrest Capital Management (UK)'s CELG Position: Q2 2014 in Review

BlueCrest Capital Management (UK) sold out of Celgene Corp (CELG) in Q2 2014, closing a stake of 6,216 shares — an estimated $434K sold.

BlueCrest Capital Management (UK) first reported a position in CELG in Q1 2014 and held it in 1 quarter. The position peaked at $434K in Q1 2014. 995 funds tracked by Wall St. Rank hold CELG as of Q2 2014.

  • BlueCrest Capital Management (UK) reported no remaining Celgene Corp position as of Q2 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 6,216 Celgene Corp shares in Q2 2014, an estimated $434K.
  • BlueCrest Capital Management (UK) first reported a position in Celgene Corp in Q1 2014 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s Celgene Corp position peaked at $434K in Q1 2014.
  • 995 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q2 2014, filed 15 Aug 2014.